A Study to Explore the Effects of Azilsartan Compared to Telmisartan on Insulin Resistance of Patients With Essential Hypertension on Type 2 Diabetes Mellitus by HOMA-R
PHASE4CompletedINTERVENTIONAL
Enrollment
33
Participants
Timeline
Start Date
June 30, 2014
Primary Completion Date
April 30, 2016
Study Completion Date
April 30, 2016
Conditions
Essential Hypertension Complicated by Type 2 Diabetes Mellitus